We are live on ! Find out more
DPLO

DIPLOMAT PHARMACY, INC.
DPLO

Delisted

DPLO was delisted on the 7th of February, 2020.

151 hedge funds and large institutions have $1.66B invested in DIPLOMAT PHARMACY, INC. in 2015 Q4 according to their latest regulatory filings, with 43 funds opening new positions, 66 increasing their positions, 30 reducing their positions, and 22 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more call options, than puts

Call options by funds: $8.11M | Put options by funds: $2.84M

120% more repeat investments, than reductions

Existing positions increased: 66 | Existing positions reduced: 30

95% more first-time investments, than exits

New positions opened: 43 | Existing positions closed: 22

50% more capital invested

Capital invested by funds: $1.1B → $1.66B (+$555M)

16% more funds holding

Funds holding: 130151 (+21)

Holders
151
Holders Change
+21
Holders Change %
+16.15%
% of All Funds
3.96%
Holding in Top 10
3
Holding in Top 10 Change
+3
Holding in Top 10 Change %
% of All Funds
0.08%
New
43
Increased
66
Reduced
30
Closed
22
Calls
$8.11M
Puts
$2.84M
Net Calls
+$5.27M
Net Calls Change
+$3.15M
Name Holding Trade Value Shares
Change
Change in
Stake
Charles Schwab
51
Charles Schwab
California
$3.78M -$59.5K -1,906 -2%
MIG
52
Mariner Investment Group
New York
$3.71M +$1.14M +36,600 +51%
PI
53
Putnam Investments
Massachusetts
$3.47M
Norges Bank
54
Norges Bank
Norway
$3.45M
William Blair & Company
55
William Blair & Company
Illinois
$3.25M -$8.22M -263,386 -74%
Morgan Stanley
56
Morgan Stanley
New York
$3.22M -$4.8M -153,943 -62%
Lazard Asset Management
57
Lazard Asset Management
New York
$3.11M +$2.84M +90,900 New
Ameriprise
58
Ameriprise
Minnesota
$2.88M +$1.12M +35,748 +74%
NLGIA
59
Nippon Life Global Investors Americas
New York
$2.77M +$2.53M +81,060 New
TD Asset Management
60
TD Asset Management
Ontario, Canada
$2.69M +$9.36K +300 +0.4%
New York State Common Retirement Fund
61
New York State Common Retirement Fund
New York
$2.61M -$115K -3,691 -5%
NFA
62
Nationwide Fund Advisors
Ohio
$2.57M +$338K +10,835 +17%
MCM
63
Mazama Capital Management
Oregon
$2.38M +$1.36M +43,536 +168%
RI
64
Redwood Investments
Massachusetts
$2.31M +$2.1M +67,432 New
California State Teachers Retirement System (CalSTRS)
65
California State Teachers Retirement System (CalSTRS)
California
$2.29M +$32.4K +1,038 +2%
FIM
66
Friedberg Investment Management
Texas
$2.19M +$2M +64,130 New
Deutsche Bank
67
Deutsche Bank
Germany
$2.17M -$1.91M -61,240 -49%
PCM
68
Palisade Capital Management
New Jersey
$2.09M +$1.28M +40,960 +205%
RCM
69
RNC Capital Management
California
$1.9M -$446K -14,285 -20%
TA
70
Teachers Advisors
New York
$1.86M -$3.71M -118,830 -69%
Swiss National Bank
71
Swiss National Bank
Switzerland
$1.63M
AAM
72
Aberdeen Asset Management
United Kingdom
$1.61M +$2.06M +66,062 New
First Trust Advisors
73
First Trust Advisors
Illinois
$1.59M +$17.9K +575 +1%
PPA
74
Parametric Portfolio Associates
Washington
$1.54M +$764K +24,477 +119%
TI
75
Turner Investments
Pennsylvania
$1.45M -$1.4M -44,720 -51%

DPLO Hedge Fund Activity: Q4 2015 in Review

151 of the 3,812 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q4 2015, worth a combined $1.66B — up 50% from $1.1B a quarter earlier.

Buyers outnumbered sellers: 43 funds opened new DPLO positions and 22 closed out — a net gain of 21 holders — while 66 added to existing stakes and 30 trimmed.

The largest buyer was Janus Henderson Investors US, adding an estimated $68M. The largest seller was Fidelity Investments, cutting an estimated $59M.

  • 151 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q4 2015, up from 130 in Q3 2015.
  • Funds reported $1.66B of DIPLOMAT PHARMACY, INC. stock for Q4 2015, up 50% quarter-over-quarter.
  • 43 funds opened new DIPLOMAT PHARMACY, INC. positions in Q4 2015 and 22 closed out, a net change of +21 holders.
  • The largest DIPLOMAT PHARMACY, INC. buyer in Q4 2015 was Janus Henderson Investors US, an estimated $68M added.
  • The largest DIPLOMAT PHARMACY, INC. seller in Q4 2015 was Fidelity Investments, an estimated $59M sold.

Based on aggregated 13F filings for Q4 2015.